SRDX - Surmodics acquires Vetex Medical

Medical device company Surmodics has acquired Vetex Medical, a Galway, Ireland-based medical device developer, at an an upfront payment of $39.9M.Vetex Medical is focused exclusively on venous clot removal solutions. The company’s first innovation product, the ReVene Thrombectomy Catheter, is engineered for use in the treatment of venous disease.Stephen Black, principal investigator and leading enroller of the VETEX feasibility study and Consultant Vascular Surgeon at Guy’s and St. Thomas’ NHS Foundation Trust, London, stated, "The ReVene Thrombectomy Catheter has the potential to significantly expand the use and accessibility of venous mechanical thrombectomy by allowing physicians to intervene early and complete the procedure in a single session. The ease of use, intuitive design and efficient performance of this device enables it to become the first-line treatment and a confident choice by venous interventionalists."The deal positions Surmodics with two FDA-approved mechanical thrombectomy devices for arterial and venous vasculature treatment.Pursuant to the deal,

For further details see:

Surmodics acquires Vetex Medical